Valuation (71%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 11.38 | 16.25 |
| PEG Ratio (TTM) | 5.14 | 1.67 |
| P/S Ratio (TTM) | 2.18 | 2.61 |
| P/B Ratio (TTM) | 1.36 | 1.90 |
| P/FCF Ratio (TTM) | 4.23 | 11.19 |
| Price to 5YR AVG Earnings Ratio | 14.83 | 14.09 |
| Price to 5YR AVG FCF Ratio | 9.57 | 8.12 |
Profitability (40%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 1.28% | 1,524.40% |
| ROE (TTM) | 12.57% | 8.88% |
| Net Profit Margin (TTM) | 19.20% | 15.63% |
| ROIC 5YR AVG | 7.95% | 20.64% |
Growth (90%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 3.99% | 31.42% | 20.57% |
| Revenue | 24.89% | 15.43% | 27.63% |
| Net Income | 4.13% | 33.97% | 23.34% |
| Cash Flow | 2,801.06% | 14.77% | 59.09% |
Health (32%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 0.05 | 3.15 |
| Quick Ratio (TTM) | 0.05 | 4.84 |
| D/E Ratio (TTM) | 0.68 | 1.27 |
| Interest Coverage (TTM) | 0.53 | 0.64 |
| Piotroski F-Score | 5 | 6 |
| Altman Z-Score | N/A | 0.38 |
| LTL to 5YR AVG FCF | 5.18 | 6.35 |
| Shares Outstanding Growth 5YR AVG | 2.58% | 4.82% |